Get notified when SMMT files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsCritical incident detected
Existential event
Time-sensitive event — see the red-flag panel below for the source-quoted detail.
Red Flags Detected
- Going Concern (new) — Summit concluded there is substantial doubt about its ability to continue as a going concern because cash at March 31, 2026 is insufficient to fund operations for the next twelve months without additional capital.
Summit Therapeutics prices $500M common stock offering at $14.11/share to fund ivonescimab trials
Filed June 10, 2026 · ~2 min read
Offering filing cluster
Same offering- 424B5 Jun 10, 2026 This filing EDGAR →
- 8-K Jun 11, 2026 Summit Therapeutics withdraws public offering citing unfavorable market conditions EDGAR →
Key Changes
-
high
Summit is offering $500.0 million of common stock at $14.11 per share (the June 8, 2026 market price), with a $75.0 million underwriter option that could bring the total to $575.0 million if exercised in full.
The Offering verify on EDGAR → -
high
Net proceeds will fund ivonescimab development including NSCLC and solid tumor trials; the company may replicate Akeso's trials but has not yet determined which trials to undertake.
Use of Proceeds verify on EDGAR → -
high
Summit has substantial doubt about its ability to continue as a going concern: cash and investments at March 31, 2026 are insufficient to fund operations for the next twelve months without this offering.
Risk Factors verify on EDGAR →
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FDS 10-Q) is open in full — no account needed.
Partner
Trade SMMT commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jul 7, 2026 · How we verify